FDA Adverse Event Injury Summary report: N

SHOCKWAVE IVL SYSTEM WITH THE SHOCKWAVE C2 CORONARY IVL CATHETER

MDR report key: 17871176 · Received October 4, 2023

Report

Report Number
3015053858-2023-00059
Event Type
Injury
Date Received
October 4, 2023
Date of Event
September 21, 2023
Report Date
May 19, 2025
Manufacturer
SHOCKWAVE MEDICAL, INC.
Product Code
QMG
UDI-DI
00195451000089
PMA / PMN Number
P200039
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
JA
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

THE DEVICE REFERENCED IN THIS REPORT WAS RETURNED TO SHOCKWAVE MEDICAL, INC. FOR INVESTIGATION. DURING THE INVESTIGATION, IT WAS FOUND THAT THE EMITTERS SHOWED SIGNS OF WEAR, INDICATING THAT THEY WERE FIRED AS EXPECTED. THE REPORTED BALLOON LOSS OF PRESSURE WAS CONFIRMED AS A PINHOLE WAS NOTED OVER EMITTER # 1. BASED ON THE REPORTED EVENT, THROMBOSIS WAS OBSERVED AT THE SITE WHERE THE COVERED STENT WAS IMPLANTED. THE THROMBOSIS WAS PERFUSED WITH MULTIPLE INFLATIONS USING BALLOON CATHETER AND PLACEMENT OF DRUG-ELUTING STENT (DES). THE CAUSE OF THE THROMBOSIS COULD NOT BE DEFINITIVELY DETERMINED. A REVIEW OF THE LOT HISTORY RECORD (LHR) AND TEST DOCUMENTATION DID NOT SHOW ANY ISSUES WITH THE MANUFACTURING OF THE DEVICE. THE DEVICE PASSED ALL SHOCKWAVE MEDICAL, INC. CRITERIA PRIOR TO BEING RELEASED FOR DISTRIBUTION. SHOCKWAVE MEDICAL, INC. HAS CONTROLS IN PLACE TO ENSURE DEVICES ARE BUILT TO APPROVED PROCEDURES AND MEET LOT RELEASE ACCEPTANCE CRITERIA PRIOR TO BEING DISTRIBUTED.

Description of Event or Problem · 0

IT WAS REPORTED THAT DURING A PROCEDURE USING A SHOCKWAVE C2 CORONARY INTRAVASCULAR (IVL) CATHETER IN THE # 7 BRANCH OF THE LEFT ANTERIOR DESCENDING ARTERY (LAD), THE IVL BALLOON DELIVERED 10 PULSES. DURING THE 2ND CYCLE, THE BALLOON DELIVERED 7 PULSES. HOWEVER, THE BALLOON WAS FLUOROSCOPICALLY OBSERVED THAT THE PRESSURE WAS DECREASING, AND THE BALLOON WAS SIMULTANEOUSLY DIMINISHING IN SIZE. DURING IMAGING, A LEAKAGE FROM THE SAME TARGET VESSEL (LAD) WAS NOTED UNDER FLUOROSCOPY SO THE PHYSICIAN IMMEDIATELY PLACED A PAPYRUS COVERED STENT TO TAMPONADE THE LEAK. POST IVL TREATMENT, FULL AND PATENT HEMOSTASIS WAS ACHIEVED. THEN THE PHYSICIAN TREATED THE DISTAL TO PROXIMAL LESION IN THE #6 BRANCH OF THE LAD. DURING THE USE OF THE IVL CATHETER, IT WAS OBSERVED THAT THERE WAS A SLOW FLOW AND THROMBOSIS WAS NOTED AT THE SITE OF THE PAPYRUS STENT THAT WAS PLACED IN THE #7 BRANCH. IT WAS ALSO NOTED THAT THE PROXIMAL PART OF THE STENT WAS NOT A PRECISE CIRCLE. THE PHYSICIAN ASPIRATED THE THROMBUS AND PERFORMED LONG INFLATIONS USING A PERFUSION BALLOON CATHETER. THEN A BIOFREEDOM DRUG-COATED CORONARY STENT (DES) WAS IMPLANTED IN THE #6 BRANCH. THE INTENDED PROCEDURE WAS COMPLETED WITH NO ADDITIONAL INTERVENTIONS.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
122632 SHOCKWAVE IVL SYSTEM WITH THE SHOCKWAVE C2 CORONARY IVL CATHETER INTRAVASCULAR LITHOTRIPSY (IVL) CATHETER QMG SHOCKWAVE MEDICAL, INC. 2.5 X 12MM 09A230531A 00195451000089

Patients

Seq Age Sex Outcome Treatment
1 79 YR Male BIOFREEDOM DES - BIOSENSORS| PAPYRUS COVERED STENT - BIOTRONIK| PERFUSION BALLOON CATHETER - UNKNOWN MFR